期刊文献+

2型糖尿病与心血管并发症研究新进展 被引量:9

Latest Researches on Type 2 Diabetes Mellitus and Cardiovascular Complications
下载PDF
导出
摘要 2型糖尿病是一种严重危害人类健康的临床常见病。近年来,其心血管病并发症越来越得到重视。但是,目前对于其确切的发生机制及有效的预防和治疗措施仍不十分明确。强化降糖治疗对心血管并发症的影响仍有争议,但早期即刻降糖治疗获益得到肯定。糖基化终末产物及炎性反应、细胞因子在心血管并发症的发生发展中起到重要作用,或可为临床提供新的治疗方向。 Diabetes mellitus is one of the most challenging health concerns of the 21st century,which is associated with a high risk of complications,especially cardiovascular events.But at present,the pathogenesis and effective prophylaxis or therapeutic regimens have not been founded.Tight glycemic control remains controversial,while early glycemic control benefits.Advanced glycation end products,vascular inflammation,and cytokines play critical role in the diabetes-associated atherosclerosis.
作者 南会兰 张蕴
出处 《医学综述》 2010年第20期3142-3145,共4页 Medical Recapitulate
关键词 2型糖尿病 降糖治疗 糖基化终末产物 细胞因子 Type 2 diabetes mellitus Glycemic control Advanced glycation end products Cytokine
  • 相关文献

参考文献20

  • 1Solomon CG.Reducing cardiovascular risk in type 2 diabetes[J].N Engl J Med,2003,348(5):457-459.
  • 2Gaede P, Pedersen O. Target intervention against multiple-risk markers to reduce cardiovascular disease in patients with type 2 diabetes[J]. Ann Med,2004,36(5) :355-366.
  • 3Gaede P,Lund-Andersen H,Parving HH,et al.Effect of a multifactorial intervention on mortality in type 2 diabetes[J].N Engl J Med,2008,358(6):580-591.
  • 4ADVANCE Collaborative Group.Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes[J].N Engl J Med,2008,358(24):2560-2572.
  • 5UK Prospective Diabetes Study(UKPDS)Croup.Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of comp lications in patientswith type 2 diabetes(UKPDS 33)[J].Lancet,1998,352(9131):837-853.
  • 6Duckworth W,Abraira C,Moritz T,et al.Glucose control and vescular complications in veterans with type 2 diabetes[J].N Engl J Med,2009,360(2):129-139.
  • 7The Action to Control Cardiovascular Risk in Diabetes Study Group.Effects of intensive glucose lowering in type 2 diabetes[J].N Engl J Med,2008,358(24):2545-2559.
  • 8Meier M,Hummel M.Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus:moving practice toward evidence-based strategies[J].Vasc Health Risk Manag,2009,5:859-871.
  • 9Skyler JS,Bergenstal R,Bonow RO,et al.Intensive Glycemic Control and the Prevention of Cardiovascular Events:Implications of the ACCORD,ADVANCE,and VA Diabetes Trials:A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association[J].Diabetes Care,2009,32(1):187-192.
  • 10Stolar M.Glycemic control and complications in type 2 diabetes mellitus[J].Am J Med,2010,123(3 Suppl):S3-S11.

二级参考文献22

  • 1Martin - Ventura JL, Blaneo - Colio LM, Munoz - Gareia Bet al. NF - kappaB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability. Stroke, 2004; 35 (2): 458-463
  • 2Monaco C, Andreakos E, Kiriakidis S et al. Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. Proc Nad Acad Sci USA, 2004; 13; 101 (15): 5634 -5639
  • 3Dormond O, Madsen JC, Bfiscoe DM. The effects of mTOR -Akt interactions on anti -apoptotic signaling in vascular endothelial cells. J Biol Chem, 2007; 10; 282 ( 32 ) : 23679 - 23686
  • 4Minhajuddin M, Fazal F, Bijli KM et al. Inhibition of mammalian target of rapamyein potentiates thrombin - induced intercellular adhesion molecule -1 expression by accelerating and stabilizing NF - kappa B activation in endothelial cells. J Immunol, 2005; 1; 174 (9) : 5823-5829
  • 5Peri S, Navarro JD, Amanehy R et al. Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res, 2003 ; 13 (10) : 2363 -2371
  • 6Kumar A, Boriek AM. Mechanical stress activates the nuclear factor - kappa B pathway in skeletal muscle fibers a possible role in Duchenne muscular dystrophy. FASEB J, 2003 ; 17 : 386 - 396
  • 7Wilkinson KD. Signal transduction: aspirin, ubiquityin and cancer. Nature, 2003 ; 424 : 738 - 739
  • 8Kiriakidis S, Andreakos E, Monaco C et al. VEGFexpression in human macrophages is NF - kB dependent: studies using adenoviruses expressing the endogenous NF - kB inhibitor IkB α and a kinase - defective form of the IkB kinase2. J Cell Science, 2003; 116 (4) : 665 -674
  • 9Wang X, Beugnet A, Murakami M et al. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E - binding proteins. Mol Cell Biol, 2005; 25 (7) : 2558 -2572
  • 10Jacinto E, Loewith R, Schmidt A et al. Mammalian TOR complex 2 controls the actin eytoskeleton and is rapamycin insensitive. Nat Cell Biol, 2004; 6 (11) : 1122-1128

共引文献11

同被引文献79

  • 1李莹,陈志红,周北凡,李义和,武阳丰,刘小清,赵连成,麦劲壮,杨军,石美玲,田秀珍,关渭全,于学海,陈磊.血脂和脂蛋白水平对我国中年人群缺血性心血管病事件的预测作用[J].中华心血管病杂志,2004,32(7):643-647. 被引量:326
  • 2李家宜.注意在儿童时期预防成人心血管病[J].中华儿科杂志,1994,32(3):137-138. 被引量:31
  • 3陈启众,张毓洪,周学仁,宋伟伟,王春玲.银川市社区2型糖尿病患者生存质量及其影响因素研究[J].宁夏医学杂志,2006,28(3):206-208. 被引量:13
  • 4曹冰燕,米杰,巩纯秀,程红,颜纯,侯冬青,刘敏,桑艳梅,朱逞.北京市19593名儿童青少年糖尿病患病现况调查[J].中华流行病学杂志,2007,28(7):631-634. 被引量:29
  • 5李秀钧.代谢综合征[M].北京:人民卫生出版社,2007:13.
  • 6Mihardja L, Delima, Manz HS, et al. Prevalence and determinants of diabetes mellitus and impaired glucose tolerance in Indonesia( a part of basic health research/riskesdas) [ J ]. Acta Med Indones - Indones J Intern Med,2009,41:169 -174.
  • 7Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus : the Stop-NIDDM randomised trial [ J ]. Lancet,2002,357 : 2072 - 2077.
  • 8Diabetes Prevention Program Research Group. Reduction in the in- cidence of type 2 diabetes with life style intervention or metformin [J]. N Engl J Med,2002,346 : 393 - 403.
  • 9United Kingdom Prospective Diabetes Study( UKPDS )Group. In- tensive blood glucose control with sulphonylureas or insulin com- pared with conventional treatment and risk of complications in pa- tients with type 2 diabetes ( UKPDS 33 ) [ J ]. Lancet, 1998,352 :.
  • 10Siminerio LM, Piatt G, Zgibor JC. Implemmenting the chronic care model for improvements in diabetes care and education in a rural primary care pra-ctice. Diabetes Edue,2005,31:225-234.

引证文献9

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部